Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Liver Neoplasms 1Fibrosis 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Enkephalin, Methionine × Gastrointestinal × Clear all
NCT00109941 2018-09-06

OGF

Milton S. Hershey Medical Center

Phase 2 Completed
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00706576 2017-08-02

Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor

University of Missouri-Columbia

Phase 1 Completed
14 enrolled
Gastrointestinal

Fibrosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡